Underweight: Trim 40-50% in tranches; retain 50-60% core at 60% normal size with hard stop at $495 and re-entry at $420-470
Underweight AMAT: trim 40-50% via tranches to remove single-price dependency, retain 50-60% core at 60% normal allocation, hard stop at $495, re-entry at $420-470. This is a meaningful reduction (not full exit) justified by 90% FCF collapse, 50x trailing multiple at cycle-peak margins (operating 31.9%, gross 49.9%, net 29.3%, ROE 39.7%), and stacked binary catalysts (Burry short, CPI, mid-August earnings) creating unfavorable asymmetry. The $8.24B cash balance and +12.8% QoQ revenue growth warrant retaining core for Terafab optionality and downside cushion. Asymmetry implies ~25% downside to low $400s versus 12-18% upside to $600-640 if everything goes perfectly.
| Position | Action |
|---|---|
| Trim 40-50% total exposure via three tranches | Execute ~one-third at market near $539, ~one-third into 50 SMA retest zone $545-555, final third into breakout above $560 (volume ≥6M shares) or weakness to $510-520 |
| Retain 50-60% core position | Size at no more than 60% of normal cyclical-equipment allocation |
| Hard stop on residual position | Exit if price falls to $495 |
AMAT is coiled for a move higher driven by accelerating revenue at all-time highs with expanding margins, the Tesla-SpaceX $16.8B Terafab project as a multi-year structural catalyst for its dominant deposition and etch tools, a fortress balance sheet with $8.24B in cash justifying the 31.6x forward P/E, and a technical bottoming pattern that has already produced a +23.5% snap-back in 7 sessions.
| Indicator | Value | Signal |
|---|---|---|
| close_10_ema | 526.89 | bullish |
| close_50_sma | 553.11 | bearish |
| close_200_sma | 380.68 | bullish |
| macd | -10.19 | neutral |
| macd_signal | -11.76 | neutral |
| macd_histogram | +1.57 | bullish |
| rsi_14 | 50.10 | neutral |
| bollinger_upper | 608.29 | — |
| bollinger_middle | 534.46 | — |
| bollinger_lower | 460.64 | — |
| atr_14 | 38.21 | — |
Support: 527 · 507 · 476.46 · 460.64 | Resistance: 553.11 · 575 · 580 · 608.29 · 640
AMAT exhibits a high-volatility bottoming attempt after a 39.7% crash from ATH, with price reclaiming the 10-day EMA (526.89) but remaining below the critical 50-day SMA at 553.11 — the main battle line between bears and bulls. The MACD histogram has turned positive (+1.57) confirming the bounce's momentum, while RSI sits neutrally at 50.10 having failed to push through 55, keeping the bear-case alive. ATR has expanded to 38.21 (2x normal), requiring position sizing to be halved and stops widened to 2x ATR (~$76); volume of 3.99M is below the 5M+ threshold needed to confirm a breakout above 553.11. Long-term trend remains structurally intact as the 200-day SMA at 380.68 is still rising and 41.6% below current price, with the lower Bollinger band at 460.64 serving as the real crash-line support.
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Price above $560
Then: Do not chase — anchors re-entry to old trim points
Terafab project is a committed multi-year capex cycle that directly benefits AMAT's deposition and etch tool dominance
· concedes: TTM P/E of 50.6x is elevated and appears expensive on backward-looking metrics; Cycle peak timing is uncertain; bear's concern about cyclical air pocket has some validity; China risk is real and already partially in the stock; Waiting for $553 confirmation is technically correct but sacrifices risk/reward
AMAT is at a cyclical peak, not an early-cycle ramp—revenue at all-time highs alongside peak margins (49.9% gross, 31.9% operating, 39.7% ROE) defines the cycle apex, and the +23.5% bounce is a bear-market rally that will reverse as the cycle rolls over in Q4 2026-Q1 2027.
· concedes: AMAT has fortress balance sheet: $8.24B cash, net debt near zero, current ratio 2.51x; Net interest income tailwind ($549M YoY) is real—it's just not new information; Revenue at $7.91B and EPS growth trajectory are real achievements; The long has 12-18% upside to $640 before major resistance (bull conceded)
→ vs conservative: Fortress balance sheet (2.51x current ratio, near-zero net debt) is rearview-mirror thinking; does not protect from multiple compression during cycle inflection
→ vs conservative: Terafab/Tesla-SpaceX $16.8 billion chip complex story already priced in after weeks of circulation; no justification to buy at 50x trailing earnings on known catalyst
→ vs conservative: Forward P/E of 32 and PEG of 1.21 only work if 60% EPS growth materializes; forward EPS of 17.05 requires perfection to sustain peak margins
→ vs conservative: Conservative analyst wants to hold full size into binary earnings event at 50x trailing earnings with beta 1.62; this is recklessness disguised as prudence
→ vs neutral: Waiting for 50 SMA reclaims at 553 with volume above 5 million or 507 break with volume results in chasing (580) or selling too late (470); paralysis masquerading as discipline
→ vs neutral: 200 SMA at 380.68 is 41% below price; watching it as secular uptrend indicator is irrelevant for 3-6 month tactical window
→ vs neutral: High-vol regime with ATR 38 and beta 1.62 guarantees getting whipped on both sides with neutral positioning; average price will be worse than decisive action
Market Cap
$428.06 B
Share Price (Implied)
~$539
52-Week High
$739.67
52-Week Low
$154.47
50-Day Moving Average
$545.41
200-Day Moving Average
$374.97
Beta (5Y)
1.618
Dividend Yield
0.4%
P/E (TTM)
50.6x
Forward P/E
31.6x
PEG Ratio
1.21
Price / Book
17.9x
Revenue TTM
$29.0B
Revenue QoQ
+12.8%
Revenue YoY
+11.4%
Q2 FY26 Revenue
$7,910M
Q1 FY26 Revenue
$7,012M
Q4 FY25 Revenue
$6,800M
Q3 FY25 Revenue
$7,302M
Q2 FY25 Revenue
$7,102M
Q1 FY25 Revenue (est.)
~$6,800M
EPS TTM
$10.66
Forward EPS
$17.05
Expected EPS Growth
+60%
Gross Margin (TTM)
~49%
Q2 FY26 Gross Margin
49.9%
Q2 FY26 Gross Profit
$3,947M
Operating Margin (TTM)
31.9%
Net Profit Margin (TTM)
29.3%
EBITDA (TTM)
$9.27B
Return on Equity (ROE)
39.7%
Return on Assets (ROA)
14.9%
Current Ratio
2.51x
Cash + ST Investments
$8.24B
Net Debt
$0.15B
Total Assets
$40.3B
Total Debt
$7.27B
Long-term Debt
$5.26B
Debt/Equity
30.4%
Stockholders' Equity
$23.9B
Working Capital
$13.57B
Inventory
$6.34B
Receivables
$6.81B
Tangible Book Value
$19.76B
Gross PPE
$10.17B
Treasury Stock
$45.8B
FCF (TTM)
$3.04B
FCF (Q2 FY26)
$210M
Operating Cash Flow (Q2 FY26)
$845M
Capital Expenditure (Q2 FY26)
$635M
Dividends Paid (Q2)
$365M
Dividends Paid (annualized)
~$1.46B
Buybacks (Q2)
$400M
Buybacks (annual pace)
~$2.0–2.5B
Shares Outstanding (diluted)
~799M
Shares Outstanding YoY Change
down from 812M
Q2 FY26 Net Income
$2,806M
Q2 FY26 Operating Income
$2,523M
Q2 FY26 Diluted EPS
$3.51
Net Interest Income (Q2 FY26)
$702M
Net Interest Income (Q2 FY25)
$153M
Special Charge (Q1 FY26)
$265M
Receivables Increase (Q2)
$1.50B
Inventory Build (Q2)
$319M
Strengths
Concerns
Applied Materials is a high-quality, cycle-leading semiconductor equipment name trading at a premium but supported by accelerating revenue, expanding margins, and a fortress balance sheet. The principal risk is cyclical — the stock has already nearly 5x'd from its 52-week low, and valuation provides limited downside cushion. A measured entry on pullbacks toward the 50-DMA ($545) or 200-DMA ($375) may be preferable to chasing at current levels, though momentum remains bullish. Position sizing should account for the elevated beta.